ES2170168T3 - Composiciones recubiertas entericamente de derivados de 1,5-benzodiacepina con actividad antagonista o agonista de cck. - Google Patents

Composiciones recubiertas entericamente de derivados de 1,5-benzodiacepina con actividad antagonista o agonista de cck.

Info

Publication number
ES2170168T3
ES2170168T3 ES95935725T ES95935725T ES2170168T3 ES 2170168 T3 ES2170168 T3 ES 2170168T3 ES 95935725 T ES95935725 T ES 95935725T ES 95935725 T ES95935725 T ES 95935725T ES 2170168 T3 ES2170168 T3 ES 2170168T3
Authority
ES
Spain
Prior art keywords
benzodiacepin
antigonist
cck
derivatives
agonist activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95935725T
Other languages
English (en)
Inventor
Elizabeth Ellen Sugg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Application granted granted Critical
Publication of ES2170168T3 publication Critical patent/ES2170168T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

FORMULACION FARMACEUTICA EN FORMA DE DOSIFICACION SOLIDA PARA LA ADMINISTRACION SOLIDA QUE INCLUYE UN COMPUESTO DE LA FORMULA GENERAL (I) O UNA SAL FISIOLOGICA DE LA ANTERIOR JUNTO CON UNO O MAS VEHICULOS ACEPTABLES FARMACEUTICAMENTE EN LOS QUE SE LA FORMULA SE ENCAJA DENTRO DE UN REVESTIMIENTO ENTERICO O UNA CAPSULA.
ES95935725T 1994-10-14 1995-10-13 Composiciones recubiertas entericamente de derivados de 1,5-benzodiacepina con actividad antagonista o agonista de cck. Expired - Lifetime ES2170168T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9420748A GB9420748D0 (en) 1994-10-14 1994-10-14 1,5 benzodiazepine derivatives

Publications (1)

Publication Number Publication Date
ES2170168T3 true ES2170168T3 (es) 2002-08-01

Family

ID=10762855

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95935725T Expired - Lifetime ES2170168T3 (es) 1994-10-14 1995-10-13 Composiciones recubiertas entericamente de derivados de 1,5-benzodiacepina con actividad antagonista o agonista de cck.

Country Status (11)

Country Link
EP (1) EP0785794B1 (es)
JP (1) JP3907700B2 (es)
AT (1) ATE210986T1 (es)
AU (1) AU3763495A (es)
DE (1) DE69524781T2 (es)
DK (1) DK0785794T3 (es)
ES (1) ES2170168T3 (es)
GB (1) GB9420748D0 (es)
PT (1) PT785794E (es)
SI (1) SI0785794T1 (es)
WO (1) WO1996011701A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6558952B1 (en) * 1992-12-14 2003-05-06 Waratah Pharmaceuticals, Inc. Treatment for diabetes
JP4530433B2 (ja) * 1996-05-07 2010-08-25 プリヴァ・ディー・ディー 脂質及びグルコースの代謝疾患治療のための方法及び組成物
IL287136B2 (en) 2016-02-05 2023-09-01 Denali Therapeutics Inc Receptor inhibitors - interacting with protein kinase 1
JP7208137B2 (ja) 2016-12-09 2023-01-18 デナリ セラピューティクス インコーポレイテッド 化合物、組成物および方法
TW202334164A (zh) 2022-01-12 2023-09-01 美商戴納立製藥公司 （Ｓ）－５－苄基－Ｎ－（５－甲基－４－側氧基－２，３，４，５－四氫吡啶並［３，２－ｂ］［１，４］氧氮呯－３－基）－４Ｈ－１，２，４－三唑－３－甲醯胺的晶型

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR890100827A (el) * 1988-12-21 1991-03-15 Abbott Lab Μέ?οδος παραγωγής παραγώγων τετραπεπτιδίων ως ανταγωνιστών CCK.
GB9201180D0 (en) * 1992-01-21 1992-03-11 Glaxo Group Ltd Chemical compounds
GB9307833D0 (en) * 1993-04-15 1993-06-02 Glaxo Inc Modulators of cholecystokinin and gastrin

Also Published As

Publication number Publication date
ATE210986T1 (de) 2002-01-15
SI0785794T1 (en) 2002-08-31
DE69524781D1 (de) 2002-01-31
PT785794E (pt) 2002-06-28
JP3907700B2 (ja) 2007-04-18
DE69524781T2 (de) 2002-06-20
EP0785794A1 (en) 1997-07-30
EP0785794B1 (en) 2001-12-19
JPH10511930A (ja) 1998-11-17
GB9420748D0 (en) 1994-11-30
AU3763495A (en) 1996-05-06
DK0785794T3 (da) 2002-03-18
WO1996011701A1 (en) 1996-04-25

Similar Documents

Publication Publication Date Title
CA2301017A1 (en) Use of propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
SE8804629D0 (sv) New therapeutically active compounds
YU13695A (sh) Upotreba 2-fenil-3-aroilbenzotiofena i njihove farmaceutske formulacije
HRP980163B1 (en) Pharmaceutical composition for the oral administration of an n-piperidinopyrazole -3-carboxamide derivative, its salts and their solvates
HUP0004383A2 (hu) Hatóanyagként klodronátot és vivőanyagként szilíciumozott mikrokristályos cellulózt tartalmazó gyógyszerészeti készítmény
EP0382077A3 (de) Diarylsubstituierte heterocyclische Verbindung, ihre Herstellung und Arzneimittel und Kosmetika daraus
DE69930648D1 (de) Orale darreichungsform für pyridin-2-ylmethylsulfinyl-1h-benzimidazole
SE8804628D0 (sv) New compounds
LV10267A (lv) Savienojums arstniecibas lidzeklis panemiens savienojuma iegusanai
IT9019112A1 (it) Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
ES2170168T3 (es) Composiciones recubiertas entericamente de derivados de 1,5-benzodiacepina con actividad antagonista o agonista de cck.
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
IT8621097A1 (it) Derivato di timo attivo per via orale, procedimenti per la sua preparazione e relative composizioni farmaceutiche
IT9021021A0 (it) Composizioni farmaceutiche per la somministrazione orale di irudina
EE200100196A (et) a-tsüklodekstriinil põhinevad farmatseutilised kompositsioonid LH-RH analoogide peroraalseks manustamiseks
IT1243702B (it) Composti ad attivita' nootropa, procedimento per la loro preparazione e relative composizioni farmaceutiche
ITMI912238A1 (it) Composti ad attivita' mucolitica e antisettica, procedimento per la loro preparazione e relative composizioni farmaceutiche
ITPD920141A0 (it) Formulazione farmaceutiche per la somministraziane orale di calcitoni-na
IT8820927A0 (it) Composto ad attivita'antiinfiammatoria, procedimento per la sua preparazione e relative composizioni farmaceutiche.
IT1157908B (it) Nuovo composto farmacologicamente attivo, procedimento per la sua preparazione e relative composizioni farmaceutiche
IT8721158A0 (it) Composto ad attivita'antiinfiammatoria, procedimento per la sua preparazione e relative composizioni farmaceutiche.
ITMI913306A1 (it) Composizioni farmaceutiche per la somministrazione nasale di polipeptidi.
ITMI920214A1 (it) Composizioni farmaceutiche stabili per la somministrazione orale di calcitonina
MX9203581A (es) Composiciones farmaceuticas de indolinas 3,3-disubstituidas, para administracion nasal.
IT1151102B (it) Composto ad attivita' analgesica,procedimento per la sua preparazione e relative composizioni farmaceutiche

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 785794

Country of ref document: ES